Glyphosate Case: Bayer to comply with court mediation order

Published On 2019-04-14 03:50 GMT   |   Update On 2019-04-14 03:50 GMT

FRANKFURT: Bayer said on Friday it would comply with a U.S. federal judge’s order to enter mediation with a plaintiff who claims the company failed to warn against an alleged cancer risk from its Roundup weedkiller.


Bayer has seen billions wiped off its market value since August when a first U.S. jury found Bayer liable because Monsanto, acquired by Bayer for $63 billion last year, had not warned of the alleged risk from Roundup, which is based on active ingredient glyphosate.


Read Also: Bayer arm liable for farmer sickness over weedkiller


It suffered a similar courtroom defeat last month and more than 10,000 cases are pending.


U.S. District Judge Vince Chhabria, who presided over the first two cases in federal court, said in a filing dated Thursday that Bayer and another plaintiff, Elaine Stevick, were ordered to start confidential mediation.


“The parties should propose a mediator in their case management statement; if they cannot agree, the Court will appoint someone,” the judge ordered, cancelling a previously scheduled May 20 trial date.


Read Also: Bayer CEO defends Monsanto deal amid Roundup rulings


Bayer said on Friday it would comply with the order in good faith while believing strongly in the “extensive body of reliable science supporting the safety of Roundup”.


“As this litigation is still in the early stages — with only two verdicts and no cases that have run their course through appeal — we will also remain focused on defending the safety of glyphosate-based herbicides in court,” it said.

Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News